The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis
Peng Zhang(Shaoxing People's Hospital), Hongliang Li(Jiangnan University), Mao-Mao Gao(Wuhan University), Zhi‐Gang She(Wuhan University), Chun‐Kai Fang(Wuhan University), Xinliang Ma(Thomas Jefferson University), Xia Yang(Wuhan University), Zan Huang(Guangzhou Maritime College), Jun Gong(Wuhan University), Xin Zhang(Academy of Military Medical Sciences), Xiao‐Jing Zhang(Wuhan University), Feng Li(First Affiliated Hospital of Guangzhou Medical University), Yan Zhang(Wuhan University), Song Tian(Wuhan University), Ling‐Ping Zhao(Wuhan University), Yuexin Lu(Weifang Medical University), Pi‐Xiao Wang(Wuhan University), Xue‐Yong Zhu(Wuhan University), Yan‐Xiao Ji(Wuhan University)
Cited by 187
Related Papers
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
|Cell Metabolism|2020|1.7k
Longitudinal Association Between Markers of Liver Injury and Mortality in COVID‐19 in China
|Hepatology|2020|448
Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia
|The FASEB Journal|1991|345